Status
Conditions
About
Background:
Objectives:
Eligibility:
Design:
<TAB>- Visit 2:
Full description
Study Description:
Up to 400 subjects with noncirrhotic portal hypertension or at risk for developing noncirrhotic portal hypertension by virtue of their
underlying disease (as well as sporadic cases of noncirrhotic portal hypertension as referred to in this protocol) will be offered inclusion
in the study.
Objectives:
Primary Objective:
findings to generate novel biomarkers that will enable improved follow-up of patients, assist in preventing complications, and
enhance transplant decision.
Secondary Objectives:
Endpoints:
Primary Endpoints:
Secondary Endpoints:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
EXCLUSION CRITERIA:
An individual who meets any of the following criteria will be excluded from participation in this study:
400 participants in 4 patient groups
Loading...
Central trial contact
Shani C Scott, R.N.; Theo Heller, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal